Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Triolab AS
AS
Active
Org 963538952
Jogstadveien 21, 2007
Kjeller
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1992 · 34 years old
41 employees
www.triolab.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Triolab AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
GL
Gøran Lysø-Jakobsen
Chief Executive Officer
Chief Executive Officer
2024
Former (1)
TE
Tove Elisabeth Hauge Nyhus
Chief Executive Officer
Chief Executive Officer
1999 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
GF
Göran Fredrik Brandt
Board of Directors
Board of Directors
2021
KT
Kai Tapani Rantanen
Chairman
Chairman
2021
Former (2)
RO
Rolf Ove Stefan Sandin
Chairman
Chairman
2018 – 2021
TE
Tove Elisabeth Hauge Nyhus
Board of Directors
Board of Directors
2021 – 2024
Shareholders
As of last annual report
Addlife Devolopment Ab — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Addlife Devolopment Ab
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Triolab AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network